Guidelines on diagnostics and treatment of acromegaly (draft)

We recommend acromegaly to be ruled in all patients with characteristic changes in appearance (A3). In all patients without characteristic changes in appearance, we recommend to rule out acromegaly, if several clinical signs suspicious for acromegaly are present (B3). We recommend acromegaly to be r...

Full description

Bibliographic Details
Published in:Ожирение и метаболизм
Main Authors: E. G. Przhiyalkovskaya, N. G. Mokrysheva, E. A. Troshina, G. A. Melnichenko, I. I. Dedov, M. B. Antsiferov, L. I. Astafieva, T. P. Bardymova, Zh. E. Belaya, G. R. Vagapova, S. Yu. Vorotnikova, A. Yu. Grigoriev, E. N. Grineva, L. K. Dzeranova, I. A. Ilovaiskaya, P. L. Kalinin, A. M. Lapshina, A. S. Lutsenko, E. O. Mamedova, E. I. Marova, M. A. Perepelova, E. A. Pigarova, V. S. Pronin, L. Ya. Rozhinskaya, Yu. Yu. Trunin, A. S. Shutova
Format: Article
Language:English
Published: Endocrinology Research Centre 2024-08-01
Subjects:
acromegaly
pituitary adenoma
growth hormone
insulin-like growth factor-1
octreotide
lanreotide
pegvisomant
Online Access:https://www.omet-endojournals.ru/jour/article/view/13153

Internet

https://www.omet-endojournals.ru/jour/article/view/13153

Similar Items